Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025

Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025

Include: 35 videos + 1 pdf, size: 4.57 GB
Target Audience: cardiologists, electrophysiologists, intensivists, heart failure specialists
 Information:

CLINICAL ADVANCES IN Heart Failure, Cardiogenic Shock and Pulmonary Hypertension SYMPOSIUM

April 25-26, 2025 San Diego Marriott La Jolla La Jolla, California

Significant advances in the diagnosis and management of heart failure and pulmonary hypertension continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these conditions. The Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium is designed to assist clinicians in correctly diagnosing, treating, and managing patients with heart failure and related conditions. In addition, the symposium will outline optimal strategies for managing
cardiogenic shock as well as new and emerging techniques for diagnosing and treating various cardiomyopathies. The symposium is dedicated to providing insight and practical tips with regard to integrating scientific evidence into clinical practice. The goal of the conference is for participants to return to their facilities equipped with the latest evidence base and strategies to improve patient outcomes.

Educational Objectives

After attending this live activity, participants should be able to:

• Incorporate current and emerging clinical evidence in the assessment, treatment, and management of patients with challenging cardiovascular disease.
• Identify guideline-recommended treatment algorithms for heart failure.
• Compare pharmacological and device therapies for cardiogenic shock.
• Identify racial and gender disparities in cardiac device selection.
• Evaluate current and emerging treatment options for cardiac amyloidosis.
• Describe clinical factors and necessary tests to establish a diagnosis of pulmonary hypertension (PH).
• Assess treatment strategies for patients with PH.
• Employ new interdisciplinary care team strategies to enhance the prevention, diagnosis, and management of various types of heart disease.

The Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025 is best for cardiologists, electrophysiologists, intensivists, heart failure specialists, and allied health professionals who want CME‑accredited, expert‑led updates on advanced management of complex cardiovascular conditions.

 Who Should Attend

• Cardiologists (general, interventional, and heart failure specialists) managing advanced heart disease.
• Electrophysiologists focusing on arrhythmia diagnosis and treatment.
• Critical care and intensive care physicians treating patients with cardiogenic shock and advanced heart failure.
• Cardiac surgeons and transplant specialists involved in mechanical circulatory support and advanced therapies.
• Nurse practitioners, physician assistants, and nurses working in cardiology, ICU, or heart failure programs.
• Residents and fellows in cardiology or critical care preparing for subspecialty practice.

 What You’ll Learn

• Latest therapies for heart failure: pharmacologic updates, device therapy, and transplant considerations.
• Arrhythmia management: advanced ablation techniques, device implantation, and guideline updates.
• Cardiogenic shock treatment: mechanical circulatory support (Impella, ECMO, LVADs) and multidisciplinary care strategies.
• Case‑based discussions: real‑world scenarios highlighting diagnostic and therapeutic challenges.
• Future directions: emerging drugs, devices, and clinical trial data shaping cardiovascular care.

 

 Topics:
Friday, April 25, 2025

• 6:45 a.m. Registration, Breakfast & View Exhibits
• 7:55 a.m. Welcome & Educational Overview
• Session I 8 a.m. Optimizing GDMT in Heart Failure Gregg Fonarow, MD
• 8:15 a.m. Racial and Gender Disparities in GDMT Utilization Gregg Fonarow, MD
• 8:30 a.m. Remote Titration to Optimize GDMT Kelly Cordero, MSN, CNS, ANP-BC
• 8:45 a.m. Population Health in Heart Failure Kelly Cordero, MSN, CNS, ANP-BC
• 9 a.m. HFpEF in Women Janet Wei, MD
• 9:15 a.m. Obesity in HFpEF and Afib Janet Wei, MD
• 9:30 a.m. Panel Discussion/Q&A
• 9:45 a.m. Break & View Exhibits
• Session II 10:15 a.m. Stages of Shock Raymond Yau, MD
• 10:30 a.m. Which Device for Which Patient: When to Escalate Raymond Yau, MD
• 10:45 a.m. Vasoplegic Shock J. Thomas Heywood, MD
• 11 a.m. Hemodynamically Unstable Pulmonary Embolism Daniel Jones, MD
• 11:15 a.m. How to Start a PERT Team Ayana Boyd King, DO
• 11:30 a.m. Right Ventricular Failure Rola Khedraki, MD
• 11:45 a.m. The Cardiogenic Shock Survivor
• Noon Panel Discussion/Q&A
• 12:30– Non-CME Lunch Symposium
• 1:15 p.m. Supported by Alnylam Pharmaceuticals
• Session III 1:30 p.m. Exercise Hemodynamics Marat Fudim, MD
• 1:45 p.m. Device-Based Therapies for HFrEF: Beyond CRT-D Marat Fudim, MD
• 2 p.m. What’s New in HFpEF Trials Rajeev Mohan, MD
• 2:15 p.m. Panel Discussion/Q&A
• 2:45 p.m. Adjourn

Saturday, April 26, 2025

• 6:45 a.m. Breakfast & View Exhibits
• 7:55 a.m. Welcome & Educational Overview
• Session IV 8 a.m. Amyloid Diagnosis and Treatment Mazen Hanna, MD
• 8:15 a.m. Emerging Therapies in Amyloid Mazen Hanna, MD
• 8:30 a.m. Hypertrophic Cardiomyopathy: Mimickers and Treatment Wael Jaber, MD
• 8:45 a.m. Advanced Imaging in the Diagnosis of Cardiomyopathies Wael Jaber, MD
• 9 a.m. Checkpoint Inhibitor Myocarditis Eric Yang, MD
• 9:15 a.m. Sarcoid Cardiomyopathy Treatment Andrew Cheng, MD
• 9:30 a.m. HCM Patient Perspective
• 9:45 a.m. Panel Discussion/Q&A
• 10 a.m. Break & View Exhibits
• Session V 10:30 a.m. Pulmonary Arterial Hypertension Diagnosis and Work Up Rola Khedraki, MD
• 10:45 a.m. Medical Therapy for Pulmonary Arterial Hypertension J. Thomas Heywood, MD
• 11 a.m. Pulmonary Hypertension Due to Lung Disease/Chronic PE Steven Zhao, MD
• 11:15 a.m. Pulmonary Hypertension and Congenital Heart Disease Laith Alshawabkeh, MD
• 11:30 a.m. Not Just the Lungs: HFpEF and Pulmonary Hypertension Rajeev Mohan, MD
• 11:45 a.m. Panel Discussion/Q&A
• 12:15– Non-CME Lunch Symposium
• 1 p.m. Supported by AstraZeneca
• Session VI 1:15 p.m. Arrhythmias and Palpitations in Women Poulina Uddin, MD
• 1:30 p.m. Racial and Gender Disparities in Cardiac Device Selection Poulina Uddin, MD
• 1:45 p.m. Cardiorenal Syndrome Jeffrey Testani, MD
• 2 p.m. GDMT in CKD and Emerging Therapies for Fluid Balance Jeffrey Testani, MD
• 2:15 p.m. Panel Discussion/Q&A

• 2:30 p.m. Adjourn